COL7A1 and recessive dystrophic epidermolysis bullosa: Noteworthy, side-by-side CRISPR/Cas9-mediated knockout of Col7a1 in NSG mice, lacking T, B, and NK cells, led to less severe RDEB and prolonged survival compared to immunocompetent C57Bl/6 mice5.